Emergent BioSolutions(美國(guó))

Emergent BioSolutions

美國(guó)EmergentBioSolutionswww.emergentbiosolutions.comEmergentBioSolutions公司是一家生物制藥企業(yè)，致力于免疫相關(guān)生物產(chǎn)品的開(kāi)發(fā)、生產(chǎn)和商業(yè)化，其產(chǎn)品包括疫苗和療法，能幫助人體免疫系統(tǒng)預(yù)防或治療疾病。Emergent的上市產(chǎn)品BioThrax®（炭疽吸附疫苗）是美國(guó)食品藥品管理局（FDA）認(rèn)可的預(yù)防炭疽感染的疫苗。Emerge nt公司準(zhǔn)備啟動(dòng)和已經(jīng)啟動(dòng)的開(kāi)發(fā)項(xiàng)目中還有側(cè)重于炭疽、肉毒中毒、傷寒、結(jié)核、乙肝和衣原體的一些計(jì)劃。EmergentBioSolutionsInc.isaleadingbiopharmaceuticalcompanydedicatedtoonesimplemission—toprotectlife.Wedevelop,manufactureandcommercializeimmunerelatedbiologics,vaccinesandbiotherapeuticsthatassistthebody’simmunesystemtopreventortreatinfectiousandotherlifethreateningdiseases.Ourmarketedproduct,BioThrax®(AnthraxVaccineAdsorbed),istheonlyvaccinelicensedbytheU.S.FoodandDrugAdministrationforthepreventionofanthraxinfection.Ourproductpipelinealsoincludes:two“nextgeneration”anthraxvaccines,twoanthraxtherapeutics(immunoglobulinandmonoclonal),twobotulinumvaccinesandabotulinumtherapeutic,anoraltyphoi